Healthcare Market Research Reports and Trends

Vascular Closure Devices Market Report Overview The large number of approvals for vascular closure devices, the high prevalence of cardiovascular diseases, high prevalance of obesity, and increasing focus of market players on large-bore vascular closure devices. The global  vascular closure devices market  is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%. On the other hand, the high cost of vascular closure devices, product recalls and failures, and increasing preference for interventional procedures using radial artery access are limiting the growth of the global market to a certain extent. The benefits of interventional cardiology procedures including reduced scarring and less pain due to their minimally invasive nature are driving the interventional cardiology market from vascular closure devices. Interventional cardiologists use vascular closure devices to close the artery after the procedure. Interventional cardiology deals specifica

Report Overview: [126 Pages Report] The  contrast injectors market  is projected to reach USD 2.4 billion by 2024 from USD 1.8 billion in 2019, at a CAGR of 6.1% during the forecast period. The major factors driving the growth of the contrast media injectors industry includes a large number of approvals for contrast agents, increasing investments, funds, and grants by government organizations, and rising demand for early diagnosis and widening the scope of clinical applications. However, the reluctance to adopt new technologies, and a shortage of trained professionals, will challenge market growth. Report Segmentations The consumables segment is expected to witness the highest growth rate during the forecast period of the contrast media injector market Based on the product, the contrast media injectors market is segmented into injector systems, consumables, and accessories. The consumables segment is expected to witness the highest growth rate during the forecast period. The high growt

Report Overview The  medical connectors market  is projected to reach USD 2.69 Billion by 2021 from USD 1.63 Billion in 2016, at a CAGR of 10.5%. The high incidence and prevalence of chronic disorders, rise in healthcare expenditure, and growth in the home healthcare market are the major factors fueling the growth of this market. To know about the assumptions considered for the study,  download the pdf brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81731061 Medical Connector Market, by Products  Flat Surgical Silicone Cables Embedded Electronics Connectors Radio-Frequency Connectors Disposable Plastic Connectors Hybrid Circular Connectors And Receptacle System Power Cords With Retention System Lighted Hospital-Grade Cords Magnetic Medical Connectors Push-Pull Connectors Medical Connector Market, by Application Patient Monitoring Devices Diagnostic Imaging Devices Electrosurgical Instruments Cardiology Devices Endoscopy Devices Respiratory Devices Analyzers And Proce

Report Overview [150 Pages Report] The global  respiratory drug delivery market  is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this market is mainly driven by increasing preference of pulmonary route of drug delivery, increasing technological developments in the form of smart/digital inhalers and rising incidences of respiratory diseases such as COPD, asthma, and cystic fibrosis. Report Segmentation The respiratory drug delivery market by formulation segment is further divided into device type and formulation type. The types of respiratory drug delivery is categorized into metered dose inhalers, dry powder inhalers, and nebulizers. The dry powder inhalers segment is expected to witness the highest growth during the forecast period due to the advantages associated with the use of these inhalers, such as short administration & preparation time, ease of use, and fewer irritant effects.

Rising geriatric population, growing prevalence of chronic diseases, increasing number of diagnostic centers, and increasing physician awareness & demand for histopathology are expected to fuel the growth of this market in the coming years. However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine offer significant growth opportunities in the immunohistochemistry market. The  immunohistochemistry market  is projected to reach USD 2.12 billion by 2021, at a CAGR of 7.3% during the forecast period.  Antibodies segment to dominate the global immunohistochemistry market Based on products, the market is segmented into antibodies, reagents, kits, and equipment. In 2015, the antibodies segment accounted for the largest share of the global immunohistochemistry market. The rising adoption of high-throughput assays, such as array comparative genomic hybridization, cDNA microarray, next-generation sequencing techniques,

Report Overview [136 Pages Report] The global  nurse call systems market  is projected to reach USD 2.5 billion by 2024 from USD 1.6 billion in 2019, at a CAGR of 9.2% from 2019 to 2024. The emerging economies such as India, China, and Brazil are expected to provide a wide range of opportunities for players in the market, which is driven by growing healthcare infrastructure, vast population pool, rising demand for quality care, and the increasing healthcare spending. Increasing incidence of Alzheimer’s disease and growing number of assisted living centers Alzheimer’s disease is a progressive disorder that causes brain cells to waste away (degenerate) and die. Also, it is the most common cause of dementia—a continuous decline in thinking, behavioral, and social skills that disrupt a person’s ability to function independently. It is estimated that approximately 5.8 million people in the US are suffering from Alzheimer’s, and the number is expected to rise to ~14 million by 2050 One of th

Infection surveillance is the ongoing systematic collection, analysis, and interpretation of healthcare-associated infections (HAIs) data essential for planning, implementation, and evaluation of public health practices, especially to curtail the rapid increase of nosocomial infections, such as central line-associated bloodstream infection (CLABSI), surgical site infection (SSI), ventilator-associated pneumonia (VAP), and catheter-associated urinary tract infection (CAUTI) in healthcare facilities. The  global infection surveillance solutions market  is estimated to reach USD 508.8 Million by 2021, at a CAGR of 14.1%  during the forecast period. The market is primarily driven by the increasing incidence of healthcare-associated infections (HAIs), government policies for preventing HAIs, rising healthcare expenditures, and increasing number of surgeries. On the other hand, factors such as high cost of software, reluctance among medical professionals to adopt advanced healthcare to

Portable analytical instruments are lightweight handheld instruments with simple infrastructure and deliver instant results, in any location and under any weather condition. The major drivers for the market include the growing food and environmental concerns; benefits of portable analytical instruments such as low cost and easy to operate; and increasing healthcare expenditure. In this report, the global  portable analytical instruments market  is segmented based on product, technology, end user, and region. By product, the market includes TOC analyzers, dissolved carbon dioxide & oxygen meters, titrators, refractometers, pH meters, spectrometers, gas analyzers, conductivity & resistivity meters, colorimeters, thermal analyzers, and others (thermometers and balances). Target Audience Manufacturers Supplier/distributors Pharmaceutical and biotechnology companies Food, beverage, and agricultural analysis companies Environmental testing organizations Academic and research institut